When was Viyash founded?

Viyash was founded in 2019 and raised its 1st funding round 1 year after it was founded.

Where is Viyash located?

Viyash is headquartered in Hyderabad, India. It is registered at 3rd Floor, Srivalli s Corporate, Plot No. 290, SYN 33 34P TO 39, Guttala Begumpet, Jubilee Hills, Hyderabad, Shaikpet, Telangana, India, 500033.

Who is the current CEO of Viyash?

Haribabu Bodepudi of Viyash. They have also founded 1 company and are an angel investors in 1 startup.

How many employees does Viyash have?

As of Aug 31, 2025, Viyash has 278 employees, reflecting a 7% year-over-year growth in headcount.

Is Viyash a funded company?

Viyash is a funded company, having raised a total of $120M across 2 funding rounds to date. The company's 1st funding round was a $***** Angel round, raised on Mar 07, 2020.

How much is Viyash worth?

The latest valuation of Viyash is ₹***** as of Jul 06, 2021. This marks a decline of 1% from its peak valuation of ₹1,860Cr in Mar, 2020. This marks a decline of 1% from its peak valuation of ₹1,860Cr in Mar, 2020.

When was the latest funding round of Viyash?

Viyash's latest funding was a $***** Angel round on Jul 05, 2021, with participation from 5 investors. Its primary sector is Biopharma Outsourcing. In India, the Biopharma Outsourcing sector has seen $270M in funding in 2026 to date.

What is the annual revenue of Viyash?

Annual revenue of Viyash is ₹1,480Cr as on Mar 31, 2025.

Where does Viyash rank among its competitors?

Viyash ranks 1st amongst 147 active competitors, of which 9 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Inventys, which secured $29.5M in Apr, 2022.

Who are the top competitors of Viyash?

Viyash's top competitors include Blue Jet Healthcare, Vivimed Labs and Optimus. Among them, Inventys secured the most recent funding round in April, 2022.

Viyash - 2026 Company Profile, Team, Funding, Competitors & Financials

Viyash is a seed company based in Hyderabad (India), founded in 2019 by Haribabu Bodepudi. It operates as a CDMO focused on manufacturing of APIs & intermediates. Viyash has raised $120M in funding, with a current valuation of ₹*****. The company has 147 active competitors, including 9 funded and 16 that have exited. Its top competitors include companies like Blue Jet Healthcare, Vivimed Labs and Optimus.

Company Details

Website: viyash.com
Email ID: *****@viyash.com
Registered Address: 3rd Floor, Srivalli s Corporate, Plot No. 290, SYN 33 34P TO 39, Guttala Begumpet, Jubilee Hills, Hyderabad, Shaikpet, Telangana, India, 500033

Key Metrics

Founded Year

2019

Location

Hyderabad, India

Stage

Seed

Total Funding

$120M in 2 rounds

Latest Funding Round

Angel, Jul 05, 2021, $*****

Post Money Valuation

₹***** as on Jul 06, 2021

Investors

Rimpal Chawla & 45 more

Ranked

1^st among 147 active competitors

Annual Revenue

₹1,480Cr as on Mar 31, 2025

Employee Count

278 as on Aug 31, 2025

Investment & Acquisitions

Symed

Similar Companies

Blue Jet Healthcare & 160 more

View Viyash's full profile

Viyash is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count
VIYASH LIFE SCIENCES PRIVATE LIMITED CIN: U24239TG2019PTC130774 , India, Amalgamated	Feb 21, 2019	$175M (As on Mar 31, 2025)	281 (As on Apr 01, 2026)
S.V. LABS PRIVATE LIMITED CIN: U24239TG2003PTC041662 , India, Amalgamated	Sep 10, 2003	$19.3M (As on Mar 31, 2025)	-
VIYASH SCIENTIFIC LIMITED CIN: L99999TS1985PLC196357 , India, Active	Jun 28, 1985	$185M (As on Mar 31, 2025)	349 (As on Feb 01, 2026)

Viyash has raised a total funding of $120M over 2 rounds. Its first funding round was on Mar 07, 2020. Its latest funding round was a Angel round on Jul 05, 2021 for $*****. 5 investors participated in its latest round. Viyash has 3 institutional investors and 43 angel investors.

Here is the list of recent funding rounds of Viyash:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 05, 2021	4176496	Angel	5245334	1222575	1632032	9460748
Mar 07, 2020	8636085	Angel	5026215	1593049	Dayakar Reddy Mallu & 32 more	8845382

Access funding benchmarks and valuations. Sign up today!

View details of Viyash's funding rounds and investors

The founders of Viyash is Haribabu Bodepudi. Haribabu Bodepudi is the CEO of Viyash.

Here are the details of Viyash's key team members:

Haribabu Bodepudi: Co-Founder & CEO of Viyash. They are also an angel investor in 1 startup and serve on the board of 1 company.
Contact Info: 1 email address and 1 phone number

Viyash's Board of Directors

Viyash's board has 6 active members. Haribabu Bodepudi, Gaddesatya Preethi and Raju Kalidindi are part of team and Gurveen Singh Khurana, CARLO DE NOTARISTEFANI and CHRISTOPHER MICHAEL CONWAY are independent board members.

Here is the list of Viyash's board of directors:

Name	Type	Representing	Status	Duration
Haribabu Bodepudi	Team	-	Current	7y 3m
Raju Kalidindi	Team	-	Current	6y 9m
nxroeeu	Team	-	Current	7y 7m
Gurveen Singh Khurana	Independent board member	-	Current	4y 2m
nkqumwj	Independent board member	-	Current	2y 2m
hwbntcj	Independent board member	-	Current	6y 7m

View details of Viyash's Founder profiles and Board Members

Viyash's employee count trend

Viyash has 278 employees as of Aug 25. The total employee count is 7.0% more than what it was in Aug 24. Here is Viyash's employee count trend over the years:

Uncover Viyash's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Viyash include Blue Jet Healthcare, Vivimed Labs and Optimus. Here is the list of Top 10 competitors of Viyash, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Viyash 2019, Hyderabad (India), Seed	CDMO focused on manufacturing of APIs & intermediates	$120M	Thecarlylegroup.fr, The Carlyle Group & 44 others	57/100
2nd	Blue Jet Healthcare 1969, Mumbai (India), Public	CDMO focused on manufacturing, supplier, and development of intermediates & APIs	-	-	57/100
3rd	Vivimed Labs 1988, Hyderabad (India), Public	Manufacturer of APIs, formulations and specialty chemicals	-	IFC, Strides Pharma Science & 5 others	51/100
4th	Optimus 2004, Hyderabad (India), Acquired	Manufacturer of APIs, intermediates, and finished formulations	$11.5M	Unichem Labs, Twine Steel & 39 others	50/100
5th	Biosynth 1966, Thal (Switzerland), Acquired	CDMO focused on manufacturing of peptides for biopharma sector	-	Ampersand Capital, Foundation for Science Innovation and Development ... & 4 others	47/100
6th	Inventys 2005, Mumbai (India), Series A	Custom based manufacturer of actives, crop protection, advanced intermediates, and specialty chemicals	$30.2M	Multi Organics, Birewar Family Trust & 18 others	46/100
7th	Veranova 2022, Wayne (United States), Acquired	CDMO focused on manufacturing of APIs and intermideates	-	-	42/100
8th	Lofty Laboratories 2005, India, Unfunded	CDMO focused on manufacturing pharmaceutical intermediates	-	-	41/100
9th	Valence Labs 2021, Rajpura (India), Unfunded	Manufacturer of pharmaceutical API for forefront of chemical innovation	-	-	41/100
10th	Sionc Pharmaceuticals 2010, Visakhapatnam (India), Unfunded	CDMO focused on manufacturing of complex and niche active pharmaceutical ingredients	-	-	39/100